Table 5. ZOONOSES of DOMESTIC ANIMALS

Total Page:16

File Type:pdf, Size:1020Kb

Table 5. ZOONOSES of DOMESTIC ANIMALS Table 5. ZOONOSES OF DOMESTIC ANIMALS INFECTIOUS PRIMARY DISEASES IN DISEASES IN PEOPLE AGENT HOST(S) ANIMALS Prions Bovine spongiform Cattle Fatal degeneration of Atypical Creutzfeldt-Jakob encephalopathy CNS disease Vaccinia virus Cattle, Papulovesiculopustular Papulovesiculopustular skin (cowpox) horses lesions of skin of udder lesions and teats Newcastle disease Poultry Respiratory, GI, CNS Conjunctivitis Paravaccinia Cattle Vesicles, ulcers, and Papulovesiculogranulomatous virus (milker's granulomas of udder skin lesions modules) Bovine pustular Sheep, goats Pustular lesions of Papulovesiculogranulomatous stomatitis virus mouth, vulva, eye skin lesions (orf, contagious ecthyma) Vesicular Cattle, Ulceration of oral Fever, chills, headache, stomatitis virus swine, horses mucosa, feet, and teats myalgia Rabies virus Dogs, cats, No apparent disease; Excitation, paralysis, death cattle, death with paralysis horses, sheep Chlamydia Pigeons, No apparent disease; Fever, cough, pneumonia psittaci poultry death Coxiella burnetii Sheep, cattle, No disease; Q fever goats (?ticks) rickettsemia Ehrlichia canis Dogs (ticks) Hemorrhagic disease, Ehrlichiosis death Afipia felis Cats, dogs No known disease Cat-scratch disease Rochalimea Cats, dogs No known disease Cat-scratch disease, peliosis henselae hepatis, bacillary angiomatosis Bacillus anthracis Cattle, Sudden death, systemic Malignant pustule, horses, disease, GI affliction gastroenteritis, pneumonitis sheep, goats, swine, dogs, cats Erysipelothrix Swine, fowl, Porcine erysipelas, Erysipeloid rhusiopathiae sheep, fish polyarthritis, septicemia, endocarditis Listeria Sheep, cattle, Meningoencephalitis, Leptomeningitis, fetal monocytogenes rabbits, abortion, myocarditis, listeriosis, septicemia, goats, guinea septicemia, oculoglandular infection pigs, ophthalmitis chickens, horses, rodents, birds Mycobacterium Cattle, Pulmonary, lymph Primarily GI, lymph node, bovis horses, nodes, udder, GI bone, pulmonary tuberculosis swine, cats, tuberculosis, dogs spondylitis Streptobacillus Fowl No apparent disease Fever, rash moniliformis Pseudomonas Horses, Nodular pneumonia, Granulomatous to pustular mallei mules, asses, farcy, lesions, skin and cats, dogs, lymphadenopathy subcutaneous; septicemia sheep, goats Pasteurella Fowl, cattle, Hemorrhagic Skin ulcer, osteomyelitis, multocida sheep, swine, septicemia, pneumonia sinusitis, pleuritis, goats, leptomeningitis horses, mice, rats, rabbits Brucella spp Cattle, goats, Abortion, lameness, Fever, malaise, swine, sheep, mastitis, granulomas, lymphadenopathy, horses, abscesses bacteremia, splenomegaly, mules, dogs, osteomyelitis cats, fowl, deer, buffalo, rabbits Capnocytophagia Dogs No apparent disease Fever, gangrene, meningitis, canimorsus septicemia Salmonella spp Fowl, swine, No apparent disease; Gastroenteritis, focal (nontyphoidal) cattle, sheep, enteritis, septicemia, infection, septicemia horses, dogs, puerperal fever cats, rodents, reptiles, birds, cattle Yersinia Dogs, cats No known disease Diarrhea, reactive arthritis enterocolitica Campylobacter Sheep, cattle Metritis, infertility, Placentitis with abortion, fetus placentitis, abortion endocarditis, bacteremia, meningitis Sporothrix Horses, Granulomas of Ulcerative, lymph-vascular, schenckii mules, dogs, extremities skin, subcutaneous lesions, cats, mice, pneumonia rats Microsporum spp Dogs, cats, Alopecia, dermatitis Alopecia, dermatitis horses, cattle Trichophyton spp Cryptosporidium Farm No apparent disease; Enteritis, dysentery spp animals, enteritis, respiratory cats, dogs disease Trypanosoma Dogs, cats No known apparent Skin rash, myocarditis, cruzi (triatomes) disease conjunctivitis, myositis, neurologic dysfunctions (Chagas disease) Balantidium coli Pigs, No apparent disease in Colitis monkeys swine; colitis in monkeys Toxoplasma Cats, dogs, Stillbirth, congenital Stillbirth, congenital defects, gondii sheep, cattle, defects, CNS lesions retinochoroiditis, encephalitis swine Ancylostoma Dogs, cats Anemia, dysentery, Itching, erythema of skin, canium hypoproteinemia, Loeffler syndrome edema, stunted growth, (Uncinaria death of pups stenocephala) Toxocara canis Dogs, cats Diarrhea, granulomas Granulomas in liver, skeletal and cati in kidneys and other muscle, lungs, brain, and eye viscera, weight loss and stunted growth of young Dipylidium Dogs, cats No apparent or known Abdominal discomfort, caninum disease; chronic diarrhea, anal pruritus enteritis Trichinella Swine, No apparent or known Chemosis, conjunctivitis, spiralis cattle, disease myositis, skin rash horses, dogs, cats, rabbits, rats, mice Taenia saginata Cattle No apparent or known Abdominal pain, diarrhea, disease weight loss Taenia solium Swine No apparent or known Abdominal pain, diarrhea, disease weight loss, cysticercosis Diphyllobothrium Dogs, cats No apparent or known Tapeworm infection, latum disease megaloblastic anemia Dirofilaria Dogs, Cardiopulmonary Pulmonary nodules, immitis, D tenuis raccoons, granulomata, subcutaneous granulomata of cats subcutaneous nodules face, trunk, or arms (mosquitoes) Echinococcus Dogs No apparent or known Space-occupying cysts in granulosus disease liver, lungs; anaphylaxis Echinococus Dogs, wild No apparent disease Noncapsulated, extensive multilocularis canines cysts, of liver, lungs and vogeli .
Recommended publications
  • WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 31/05 (2006.01) A61P 31/02 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/CA20 14/000 174 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, 4 March 2014 (04.03.2014) KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (25) Filing Language: English OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (26) Publication Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (30) Priority Data: ZW. 13/790,91 1 8 March 2013 (08.03.2013) US (84) Designated States (unless otherwise indicated, for every (71) Applicant: LABORATOIRE M2 [CA/CA]; 4005-A, rue kind of regional protection available): ARIPO (BW, GH, de la Garlock, Sherbrooke, Quebec J1L 1W9 (CA). GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (72) Inventors: LEMIRE, Gaetan; 6505, rue de la fougere, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, Sherbrooke, Quebec JIN 3W3 (CA).
    [Show full text]
  • Bacterial Infections Diseases Picture Cause Basic Lesion
    page: 117 Chapter 6: alphabetical Bacterial infections diseases picture cause basic lesion search contents print last screen viewed back next Bacterial infections diseases Impetigo page: 118 6.1 Impetigo alphabetical Bullous impetigo Bullae with cloudy contents, often surrounded by an erythematous halo. These bullae rupture easily picture and are rapidly replaced by extensive crusty patches. Bullous impetigo is classically caused by Staphylococcus aureus. cause basic lesion Basic Lesions: Bullae; Crusts Causes: Infection search contents print last screen viewed back next Bacterial infections diseases Impetigo page: 119 alphabetical Non-bullous impetigo Erythematous patches covered by a yellowish crust. Lesions are most frequently around the mouth. picture Lesions around the nose are very characteristic and require prolonged treatment. ß-Haemolytic streptococcus is cause most frequently found in this type of impetigo. basic lesion Basic Lesions: Erythematous Macule; Crusts Causes: Infection search contents print last screen viewed back next Bacterial infections diseases Ecthyma page: 120 6.2 Ecthyma alphabetical Slow and gradually deepening ulceration surmounted by a thick crust. The usual site of ecthyma are the legs. After healing there is a permanent scar. The pathogen is picture often a streptococcus. Ecthyma is very common in tropical countries. cause basic lesion Basic Lesions: Crusts; Ulcers Causes: Infection search contents print last screen viewed back next Bacterial infections diseases Folliculitis page: 121 6.3 Folliculitis
    [Show full text]
  • WO 2013/042140 A4 28 March 2013 (28.03.2013) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2013/042140 A4 28 March 2013 (28.03.2013) P O P C T (51) International Patent Classification: NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, A61K 31/197 (2006.01) A61K 45/06 (2006.01) RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, A61K 31/60 (2006.01) A61P 31/00 (2006.01) TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, A61K 33/22 (2006.01) ZM, ZW. (21) International Application Number: (84) Designated States (unless otherwise indicated, for every PCT/IN20 12/000634 kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, (22) International Filing Date UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, 24 September 2012 (24.09.2012) TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, (25) Filing Language: English EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, (26) Publication Language: English TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, (30) Priority Data: ML, MR, NE, SN, TD, TG). 2792/DEL/201 1 23 September 201 1 (23.09.201 1) IN Declarations under Rule 4.17 : (72) Inventor; and — of inventorship (Rule 4.17(iv)) (71) Applicant : CHAUDHARY, Manu [IN/IN]; 51-52, In dustrial Area Phase- 1, Panchkula 1341 13 (IN).
    [Show full text]
  • SNF Mobility Model: ICD-10 HCC Crosswalk, V. 3.0.1
    The mapping below corresponds to NQF #2634 and NQF #2636. HCC # ICD-10 Code ICD-10 Code Category This is a filter ceThis is a filter cellThis is a filter cell 3 A0101 Typhoid meningitis 3 A0221 Salmonella meningitis 3 A066 Amebic brain abscess 3 A170 Tuberculous meningitis 3 A171 Meningeal tuberculoma 3 A1781 Tuberculoma of brain and spinal cord 3 A1782 Tuberculous meningoencephalitis 3 A1783 Tuberculous neuritis 3 A1789 Other tuberculosis of nervous system 3 A179 Tuberculosis of nervous system, unspecified 3 A203 Plague meningitis 3 A2781 Aseptic meningitis in leptospirosis 3 A3211 Listerial meningitis 3 A3212 Listerial meningoencephalitis 3 A34 Obstetrical tetanus 3 A35 Other tetanus 3 A390 Meningococcal meningitis 3 A3981 Meningococcal encephalitis 3 A4281 Actinomycotic meningitis 3 A4282 Actinomycotic encephalitis 3 A5040 Late congenital neurosyphilis, unspecified 3 A5041 Late congenital syphilitic meningitis 3 A5042 Late congenital syphilitic encephalitis 3 A5043 Late congenital syphilitic polyneuropathy 3 A5044 Late congenital syphilitic optic nerve atrophy 3 A5045 Juvenile general paresis 3 A5049 Other late congenital neurosyphilis 3 A5141 Secondary syphilitic meningitis 3 A5210 Symptomatic neurosyphilis, unspecified 3 A5211 Tabes dorsalis 3 A5212 Other cerebrospinal syphilis 3 A5213 Late syphilitic meningitis 3 A5214 Late syphilitic encephalitis 3 A5215 Late syphilitic neuropathy 3 A5216 Charcot's arthropathy (tabetic) 3 A5217 General paresis 3 A5219 Other symptomatic neurosyphilis 3 A522 Asymptomatic neurosyphilis 3 A523 Neurosyphilis,
    [Show full text]
  • Pseudomonas Skin Infection Clinical Features, Epidemiology, and Management
    Am J Clin Dermatol 2011; 12 (3): 157-169 THERAPY IN PRACTICE 1175-0561/11/0003-0157/$49.95/0 ª 2011 Adis Data Information BV. All rights reserved. Pseudomonas Skin Infection Clinical Features, Epidemiology, and Management Douglas C. Wu,1 Wilson W. Chan,2 Andrei I. Metelitsa,1 Loretta Fiorillo1 and Andrew N. Lin1 1 Division of Dermatology, University of Alberta, Edmonton, Alberta, Canada 2 Department of Laboratory Medicine, Medical Microbiology, University of Alberta, Edmonton, Alberta, Canada Contents Abstract........................................................................................................... 158 1. Introduction . 158 1.1 Microbiology . 158 1.2 Pathogenesis . 158 1.3 Epidemiology: The Rise of Pseudomonas aeruginosa ............................................................. 158 2. Cutaneous Manifestations of P. aeruginosa Infection. 159 2.1 Primary P. aeruginosa Infections of the Skin . 159 2.1.1 Green Nail Syndrome. 159 2.1.2 Interdigital Infections . 159 2.1.3 Folliculitis . 159 2.1.4 Infections of the Ear . 160 2.2 P. aeruginosa Bacteremia . 160 2.2.1 Subcutaneous Nodules as a Sign of P. aeruginosa Bacteremia . 161 2.2.2 Ecthyma Gangrenosum . 161 2.2.3 Severe Skin and Soft Tissue Infection (SSTI): Gangrenous Cellulitis and Necrotizing Fasciitis. 161 2.2.4 Burn Wounds . 162 2.2.5 AIDS................................................................................................. 162 2.3 Other Cutaneous Manifestations . 162 3. Antimicrobial Therapy: General Principles . 163 3.1 The Development of Antibacterial Resistance . 163 3.2 Anti-Pseudomonal Agents . 163 3.3 Monotherapy versus Combination Therapy . 164 4. Antimicrobial Therapy: Specific Syndromes . 164 4.1 Primary P. aeruginosa Infections of the Skin . 164 4.1.1 Green Nail Syndrome. 164 4.1.2 Interdigital Infections . 165 4.1.3 Folliculitis .
    [Show full text]
  • Skin Disease and Disorders
    Sports Dermatology Robert Kiningham, MD, FACSM Department of Family Medicine University of Michigan Health System Disclosures/Conflicts of Interest ◼ None Goals and Objectives ◼ Review skin infections common in athletes ◼ Establish a logical treatment approach to skin infections ◼ Discuss ways to decrease the risk of athlete’s acquiring and spreading skin infections ◼ Discuss disqualification and return-to-play criteria for athletes with skin infections ◼ Recognize and treat non-infectious skin conditions in athletes Skin Infections in Athletes ◼ Bacterial ◼ Herpetic ◼ Fungal Skin Infections in Athletes ◼ Very common – most common cause of practice-loss time in wrestlers ◼ Athletes are susceptible because: – Prone to skin breakdown (abrasions, cuts) – Warm, moist environment – Close contacts Cases 1 -3 ◼ 21 year old male football player with 4 day h/o left axillary pain and tenderness. Two days ago he noticed a tender “bump” that is getting bigger and more tender. ◼ 16 year old football player with 3 day h/o mildly tender lesions on chin. Started as a single lesion, but now has “spread”. Over the past day the lesions have developed a dark yellowish crust. ◼ 19 year old wrestler with a 3 day h/o lesions on right side of face. Noticed “tingling” 4 days ago, small fluid filled lesions then appeared that have now started to crust over. Skin Infections Bacterial Skin Infections ◼ Cellulitis ◼ Erysipelas ◼ Impetigo ◼ Furunculosis ◼ Folliculitis ◼ Paronychea Cellulitis Cellulitis ◼ Diffuse infection of connective tissue with severe inflammation of dermal and subcutaneous layers of the skin – Triad of erythema, edema, and warmth in the absence of underlying foci ◼ S. aureus or S. pyogenes Erysipelas Erysipelas ◼ Superficial infection of the dermis ◼ Distinguished from cellulitis by the intracutaneous edema that produces palpable margins of the skin.
    [Show full text]
  • Necrotizing Fasciitis Report of 39 Pediatric Cases
    STUDY Necrotizing Fasciitis Report of 39 Pediatric Cases Antonio Fustes-Morales, MD; Pedro Gutierrez-Castrellon, MD; Carola Duran-Mckinster, MD; Luz Orozco-Covarrubias, MD; Lourdes Tamayo-Sanchez, MD; Ramon Ruiz-Maldonado, MD Background: Necrotizing fasciitis (NF) is a severe, Results: We examined 39 patients with NF (0.018% of life-threatening soft tissue infection. General features all hospitalized patients). Twenty-one patients (54%) were and risk factors for fatal outcome in children are not boys. Mean age was 4.4 years. Single lesions were seen in well known. 30 (77%) of patients, with 21(54%) in extremities. The most frequent preexisting condition was malnutrition in 14 pa- Objective: To characterize the features of NF in chil- tients (36%). The most frequent initiating factor was vari- dren and the risk factors for fatal outcome. cella in 13 patients (33%). Diagnosis of NF at admission was made in 11 patients (28%). Bacterial isolations in 24 Design: Retrospective, comparative, observational, and patients (62%) were polymicrobial in 17 (71%). Pseudo- longitudinal trial. monas aeruginosa was the most frequently isolated bacte- ria; gram-negative isolates, the most frequently associated Setting: Dermatology department of a tertiary care pe- bacteria. Complications were present in 33 patients (85%), diatric hospital. mortality in 7 (18%), and sequelae in 29 (91%) of 32 sur- viving patients. The significant risk factor related to a fatal Patients: All patients with clinical and/or histopatho- outcome was immunosuppression. logical diagnosis of NF seen from January 1, 1971, through December 31, 2000. Conclusions: Necrotizing fasciitis in children is fre- quently misdiagnosed, and several features differ from those Main Outcome Variables: Incidence, age, sex, num- of NF in adults.
    [Show full text]
  • Z:\My Documents\WPDOCS\IACUC
    ZOONOTIC DISEASES OF LABORATORY, AGRICULTURAL, AND WILDLIFE ANIMALS July, 2007 Michael S. Rand, DVM, DACLAM University Animal Care University of Arizona PO Box 245092 Tucson, AZ 85724-5092 (520) 626-6705 E-mail: [email protected] http://www.ahsc.arizona.edu/uac Table of Contents Introduction ............................................................................................................................................. 3 Amebiasis ............................................................................................................................................... 5 B Virus .................................................................................................................................................... 6 Balantidiasis ........................................................................................................................................ 6 Brucellosis ........................................................................................................................................ 6 Campylobacteriosis ................................................................................................................................ 7 Capnocytophagosis ............................................................................................................................ 8 Cat Scratch Disease ............................................................................................................................... 9 Chlamydiosis .....................................................................................................................................
    [Show full text]
  • Skin and Soft Tissue Infections Following Marine Injuries
    CHAPTER 6 Skin and Soft Tissue Infections Following Marine Injuries V. Savini, R. Marrollo, R. Nigro, C. Fusella, P. Fazii Spirito Santo Hospital, Pescara, Italy 1. INTRODUCTION Bacterial diseases following aquatic injuries occur frequently worldwide and usually develop on the extremities of fishermen and vacationers, who are exposed to freshwater and saltwater.1,2 Though plenty of bacterial species have been isolated from marine lesions, superficial soft tissue and invasive systemic infections after aquatic injuries and exposures are related to a restricted number of microorganisms including, in alphabetical order, Aeromonas hydrophila, Chromobacterium violaceum, Edwardsiella tarda, Erysipelothrix rhusiopathiae, Myco- bacterium fortuitum, Mycobacterium marinum, Shewanella species, Streptococcus iniae, and Vibrio vulnificus.1,2 In particular, skin disorders represent the third most common cause of morbidity in returning travelers and are usually represented by bacterial infections.3–12 Bacterial skin and soft tissue infectious conditions in travelers often follow insect bites and can show a wide range of clinical pictures including impetigo, ecthyma, erysipelas, abscesses, necro- tizing cellulitis, myonecrosis.3–12 In general, even minor abrasions and lacerations sustained in marine waters should be considered potentially contaminated with marine bacteria.3–12 Despite variability of the causative agents and outcomes, the initial presentations of skin and soft tissue infections (SSTIs) complicating marine injuries are similar to those occurring after terrestrial exposures and usually include erysipelas, impetigo, cellulitis, and necrotizing infections.3 Erysipelas is characterized by fiery red, tender, painful plaques showing well-demarcated edges, and, though Streptococcus pyogenes is the major agent of this pro- cess, E. rhusiopathiae infections typically cause erysipeloid displays.3 Impetigo is initially characterized by bullous lesions and is usually due to Staphylococcus aureus or S.
    [Show full text]
  • Skin and Soft Ssue Infec On
    Skin and so* +ssue infec+on N.Nuntachit MD. Non purulent SSTI • Impe+go, ecthyma • Celluli+s, Erysipelas • Erysipeloid • Necro+zing infec+on • Etc eg Glanders, bubonic plaque Purulent SSTI • Furuncle • Carbuncle • Abscess • Etc eg Tularemia SSTI severity • Purulent SSTI – Mild infec+on: I&D is indicated – Moderate: + systemic signs – Severe: failed I&D + ABT, systemic signs • Non purulent SSTI – Mild infec+on: no focus of purulence – Moderate: + systemic signs – Severe: failed oral ABTs, systemic signs, compromised, signs of deeper infecon Impe+go, Ecthyma • S.aureus or Beta hemoly+c streptococci • Difference – Depth – Scar • ABT should be ac+ve against both S. aureus and streptococci • Systemic therapy preferred – Pts with numerous lesions – Outbreaks Treatment An#bio#c Dosage Comment Dicloxacillin 250 mg po qid Cephalexin 250 mg po qid Erythromycin 250 mg po qid Some strains of Staphylococcus aureus and Streptococcus pyogenes may be resistant Clindamycin 300-400 mg po qid Amoxicillin-clavulanate 875/125 mg po bid Retapamulin ointment Apply lesions bid For paents with limited number of lesions Mupirocin ointment Apply lesions bid For paents with limited number of lesions Celluli+s, Erysipelas • Erysipelas • Cellulis – Upper dermis – Deeper dermis, – Delineated border subcutaneous fat – May be refer to celluli+s – No clear border of face • Areas of erythema, swelling, tenderness, and warmth, some+mes accompanied by lymphangi+s and inflammaon of the regional lymph nodes. The skin surface may resemble an orange peel (peau d’orange) Celluli+s,
    [Show full text]
  • Investigation of Swabs from Skin and Superficial Soft Tissue Infections
    UK Standards for Microbiology Investigations Investigation of swabs from skin and superficial soft tissue infections Issued by the Standards Unit, Microbiology Services, PHE Bacteriology | B 11 | Issue no: 6.5 | Issue date: 19.12.18 | Page: 1 of 37 © Crown copyright 2018 Investigation of swabs from skin and superficial soft tissue infections Acknowledgments UK Standards for Microbiology Investigations (SMIs) are developed under the auspices of Public Health England (PHE) working in partnership with the National Health Service (NHS), Public Health Wales and with the professional organisations whose logos are displayed below and listed on the website https://www.gov.uk/uk- standards-for-microbiology-investigations-smi-quality-and-consistency-in-clinical- laboratories. SMIs are developed, reviewed and revised by various working groups which are overseen by a steering committee (see https://www.gov.uk/government/groups/standards-for-microbiology-investigations- steering-committee). The contributions of many individuals in clinical, specialist and reference laboratories who have provided information and comments during the development of this document are acknowledged. We are grateful to the medical editors for editing the medical content. For further information please contact us at: Standards Unit Microbiology Services Public Health England 61 Colindale Avenue London NW9 5EQ E-mail: [email protected] Website: https://www.gov.uk/uk-standards-for-microbiology-investigations-smi-quality- and-consistency-in-clinical-laboratories PHE publications gateway number: 2016056 UK Standards for Microbiology Investigations are produced in association with: Logos correct at time of publishing. Bacteriology | B 11 | Issue no: 6.5 | Issue date: 19.12.18 | Page: 2 of 37 UK Standards for Microbiology Investigations | Issued by the Standards Unit, Public Health England Investigation of swabs from skin and superficial soft tissue infections Contents Acknowledgments ................................................................................................................
    [Show full text]
  • Ecthyma Gangrenosum: a Rare Cutaneous Manifestation Caused by Stenotrophomonas Maltophilia in a Leukemic Patient
    Ann Dermatol Vol. 21, No. 4, 2009 CASE REPORT Ecthyma Gangrenosum: A Rare Cutaneous Manifestation Caused by Stenotrophomonas maltophilia in a Leukemic Patient Young Min Son, M.D., So Young Na, M.D., Hye Young Lee, M.D., Jin Ok Baek, M.D., Jong Rok Lee, M.D., Joo Young Roh, M.D. Department of Dermatology, Gachon University of Medicine and Science, Gil Medical Center, Incheon, Korea Ecthyma gangrenosum (EG) is a well-recognized cutaneous pressed and burn patients1,2. It usually occurs as a result of infection that most commonly affects immunocompromised bacteremia or, rarely, as a primary cutaneous lesion. The patients. It typically occurs on the extremities, or in gluteal lesions are present in the gluteal and perineal regions or and perineal regions. Although Pseudomonas aeruginosa is on the extremities, but they can occur anywhere on the the most well-known pathogen causing EG, other organisms body1,3,4. Most cases of ecthyma gangrenosum are asso- have been reported to cause EG. Herein we report a rare case ciated with Pseudomonas aeruginosa bacteremia5,6. But of ecthyma gangrenosum presenting as aggressive necrotic numerous other organisms have been reported to cause skin lesions in perioral and infraorbital areas in a 47-year-old EG. patient with acute myelocytic leukemia after allogeneic Stenotrophomonas maltophilia is an aerobic gram-neg- bone marrow transplantation. It was caused by Stenotropho- ative bacillus that is a frequent colonizer of fluids used in monas maltophilia, which is an aerobic, gram-negative hospital settings. The incidence of S. maltophilia infection pathogen that has been associated only rarely with cuta- has been increasing.
    [Show full text]